Supremin Cough suppressant medicine syrup 200 ml
100% secure payments
zł21.33
Tax included
Description
Supremin Cough suppressant medicine syrup 200 ml
Description
Supremin
Butamirati citras
Medicine with antitussive effect
4 mg / 5 ml
Syrup
OTC - Medication dispensed without a prescription.
Butamirati citras
Medicine with antitussive effect
4 mg / 5 ml
Syrup
OTC - Medication dispensed without a prescription.
Storage and use
Read the leaflet before using the drug.
Dosage and method of administration:
Oral administration.
The drug should be taken before meals.
Unless the doctor prescribes a special dosage, the drug is most often used:
Age Children aged 2 to 6 years / Dosage 1 measuring teaspoon (4 mg) 3 times daily.
Age Children 6 to 12 years / Dosage 2 measuring teaspoons (8 mg) 3 times a day
Age Children over 12 years / Dosage 3 measuring teaspoons (12 mg) 3 times daily
Ages Adults / Dosage 3 measuring teaspoons (12 mg) 4 times daily
Storage: Store at ambient temperature
Packaging: Box
Dosage and method of administration:
Oral administration.
The drug should be taken before meals.
Unless the doctor prescribes a special dosage, the drug is most often used:
Age Children aged 2 to 6 years / Dosage 1 measuring teaspoon (4 mg) 3 times daily.
Age Children 6 to 12 years / Dosage 2 measuring teaspoons (8 mg) 3 times a day
Age Children over 12 years / Dosage 3 measuring teaspoons (12 mg) 3 times daily
Ages Adults / Dosage 3 measuring teaspoons (12 mg) 4 times daily
Storage: Store at ambient temperature
Packaging: Box
Composition
5 ml (1 measuring spoon) of syrup contains as active substance 4 mg of citrate butamirate, Excipients: benzoic acid, methyl parahydroxybenzoate, aspartame, liquid maltitol and others
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Manufacturer's address
Responsible party:
Teva Pharmaceuticals Polska Sp. z o.o.
53 Emilii Plater St.
00-113 Warsaw
Safety warning
Teva Pharmaceuticals Polska Sp. z o.o.
53 Emilii Plater St.
00-113 Warsaw
Keep the drug out of sight and reach of children.
General information
Carefully read the leaflet before taking the drug, as it contains important information for the patient.
Always take this medication exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
- Keep this leaflet so that you can read it again if necessary.
- If you need advice or additional information, ask your pharmacist.
- If you experience any side effects, including any possible side effects not listed in the leaflet, tell your doctor or pharmacist. See section 4.
- If there is no improvement or the patient feels worse, contact your doctor.
Table of contents of the leaflet
Always take this medication exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
- Keep this leaflet so that you can read it again if necessary.
- If you need advice or additional information, ask your pharmacist.
- If you experience any side effects, including any possible side effects not listed in the leaflet, tell your doctor or pharmacist. See section 4.
- If there is no improvement or the patient feels worse, contact your doctor.
Table of contents of the leaflet:
1 What is Supremin drug and for what purpose it is used.
2. important information before using Supremin drug
3 How to use the drug Supremin
4 Possible side effects
5. how to store the drug Supremin
6. package contents and other information
Description and application
1 What is Supremin drug and for what purpose it is used.
2. important information before using Supremin drug
3 How to use the drug Supremin
4 Possible side effects
5. how to store the drug Supremin
6. package contents and other information
1 What is the drug Supremin and for what purpose it is used.
The drug Supremin in the form of syrup contains butamirate citrate as an active substance, which is a non-opioid cough suppressant. It reduces the frequency and intensity of coughing by inhibiting the cough reflex. In addition to its antitussive effect, butamirate slightly dilates the bronchi.
Indications for use: acute dry cough.
How to use the drug
The drug Supremin in the form of syrup contains butamirate citrate as an active substance, which is a non-opioid cough suppressant. It reduces the frequency and intensity of coughing by inhibiting the cough reflex. In addition to its antitussive effect, butamirate slightly dilates the bronchi.
Indications for use: acute dry cough.
3 How to use the drug Supremin
This drug should always be used exactly as described in the leaflet for patients or as prescribed by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
Oral administration.
The drug should be taken before meals.
The package of the drug comes with a measuring spoon for measuring 5 ml of syrup.
Unless the doctor prescribes a special dosage, the drug is most often used:
- children aged 2 to 6 years 1 measuring spoon (4 mg) 3 times a day.
- children aged 6 to 12 years 2 measuring teaspoons (8 mg) 3 times a day
- children over 12 years old 3 measuring teaspoons (12 mg) 3 times a day
- adults 3 measuring teaspoons (12 mg) 4 times a day
If you feel that the effect of the drug is too strong or too weak, contact your doctor.
Taking more than the recommended dose of the drug Supremin
Symptoms of butamirate overdose include drowsiness, vomiting, abdominal pain, diarrhea, ataxia (impaired motor coordination), agitation and decreased blood pressure. In the event of an overdose, seek immediate medical attention, who may perform gastric lavage, administer activated charcoal and laxatives.
Omission of use of the drug Supremin
The drug should be taken as soon as the patient remembers it. When the time for the next dose is approaching, take it at the scheduled time. Do not use a double dose to make up for a missed dose.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
How to store the drug
This drug should always be used exactly as described in the leaflet for patients or as prescribed by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
Oral administration.
The drug should be taken before meals.
The package of the drug comes with a measuring spoon for measuring 5 ml of syrup.
Unless the doctor prescribes a special dosage, the drug is most often used:
- children aged 2 to 6 years 1 measuring spoon (4 mg) 3 times a day.
- children aged 6 to 12 years 2 measuring teaspoons (8 mg) 3 times a day
- children over 12 years old 3 measuring teaspoons (12 mg) 3 times a day
- adults 3 measuring teaspoons (12 mg) 4 times a day
If you feel that the effect of the drug is too strong or too weak, contact your doctor.
Taking more than the recommended dose of the drug Supremin
Symptoms of butamirate overdose include drowsiness, vomiting, abdominal pain, diarrhea, ataxia (impaired motor coordination), agitation and decreased blood pressure. In the event of an overdose, seek immediate medical attention, who may perform gastric lavage, administer activated charcoal and laxatives.
Omission of use of the drug Supremin
The drug should be taken as soon as the patient remembers it. When the time for the next dose is approaching, take it at the scheduled time. Do not use a double dose to make up for a missed dose.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
5 How to store the drug Supremin
Store the drug out of sight and reach of children.
Store at a temperature below 25°C.
Do not use this drug after the expiration date placed on the box and bottle after: Expiration date. Expiration date means the last day of the month stated.
Expiration date after first opening: 28 days.
Medicines should not be disposed of down the drain or in household waste containers. Ask your pharmacist how to dispose of medicines that you no longer use. Such treatment will help protect the environment.
Possible side effects
Store the drug out of sight and reach of children.
Store at a temperature below 25°C.
Do not use this drug after the expiration date placed on the box and bottle after: Expiration date. Expiration date means the last day of the month stated.
Expiration date after first opening: 28 days.
Medicines should not be disposed of down the drain or in household waste containers. Ask your pharmacist how to dispose of medicines that you no longer use. Such treatment will help protect the environment.
4 Possible side effects
Like any drug, this medication may cause side effects, although they will not occur in everyone.
Side effects are not very common (less than 1 in 100 people):
rash, nausea, diarrhea, dizziness.
The described symptoms usually resolve during treatment and rarely require a reduction in the dose of the drug.
If the described allergic reactions or gastrointestinal disorders do not resolve after reducing the drug dose, Supremin should be discontinued.
Reporting of side effects
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor or pharmacist. Adverse reactions can be reported directly to the Adverse Drug Reactions Monitoring Department of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw,
Tel: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the responsible party.
By reporting side effects, more information on the safety of the drug can be gathered.
Package contents and other information
Like any drug, this medication may cause side effects, although they will not occur in everyone.
Side effects are not very common (less than 1 in 100 people):
rash, nausea, diarrhea, dizziness.
The described symptoms usually resolve during treatment and rarely require a reduction in the dose of the drug.
If the described allergic reactions or gastrointestinal disorders do not resolve after reducing the drug dose, Supremin should be discontinued.
Reporting of side effects
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor or pharmacist. Adverse reactions can be reported directly to the Adverse Drug Reactions Monitoring Department of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw,
Tel: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the responsible party.
By reporting side effects, more information on the safety of the drug can be gathered.
6 Package contents and other information
What the drug Supremin contains
- The active substance of the drug is butamirate citrate. 5 ml (1 measuring spoon) of the syrup contains 4 mg of butamirate citrate.
- The other ingredients of the drug are: methyl parahydroxybenzoate, benzoic acid, citric acid anhydrous, sodium citrate, liquid maltitol, aspartame, caramel-orange flavor (E 34493) (contains, among others, propylene glycol, ethanol, benzyl alcohol), purified water.
What the drug Supremin looks like and what the package contains
Syrup in a brown glass bottle with an aluminum cap or a polypropylene cap along with a polystyrene measuring spoon, in a cardboard box or a brown glass bottle closed with a polyethylene cap made of HDPE (high-density polyethylene) and a guarantee ring made of PE (polyethylene), along with a polystyrene measuring spoon, in a cardboard box.
Bottle containing 200 ml of syrup in a cardboard box also containing a 5 ml measuring spoon.
Responsible entity and manufacturer
Responsible party:
Teva Pharmaceuticals Polska Sp. z o.o.
53 Emilii Plater St.
00-113 Warsaw
Tel: (22) 345 93 00
Manufacturer:
Balkanpharma Troyan AD
1, Krayrechna Str.
5600 Troyan
Bulgaria
Important before use
What the drug Supremin contains
- The active substance of the drug is butamirate citrate. 5 ml (1 measuring spoon) of the syrup contains 4 mg of butamirate citrate.
- The other ingredients of the drug are: methyl parahydroxybenzoate, benzoic acid, citric acid anhydrous, sodium citrate, liquid maltitol, aspartame, caramel-orange flavor (E 34493) (contains, among others, propylene glycol, ethanol, benzyl alcohol), purified water.
What the drug Supremin looks like and what the package contains
Syrup in a brown glass bottle with an aluminum cap or a polypropylene cap along with a polystyrene measuring spoon, in a cardboard box or a brown glass bottle closed with a polyethylene cap made of HDPE (high-density polyethylene) and a guarantee ring made of PE (polyethylene), along with a polystyrene measuring spoon, in a cardboard box.
Bottle containing 200 ml of syrup in a cardboard box also containing a 5 ml measuring spoon.
Responsible entity and manufacturer
Responsible party:
Teva Pharmaceuticals Polska Sp. z o.o.
53 Emilii Plater St.
00-113 Warsaw
Tel: (22) 345 93 00
Manufacturer:
Balkanpharma Troyan AD
1, Krayrechna Str.
5600 Troyan
Bulgaria
2 Information important before using Supremin drug
When not to use Supremin drug:
- if the patient is allergic to butamirate or any of the other ingredients of this drug (listed in section 6),
- in patients with phenylketonuria.
Warnings and precautions
Supremin drug is not indicated for use in patients with symptoms of severe respiratory inhibition. The drug should not be used for more than a few days.
Supremin and other drugs
There are no known interactions of the drug Supremin with other drugs.
Supremin with food and drink
The drug should be taken before meals.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, suspect that you may be pregnant or if you are planning to have a child, you should consult your doctor before taking this drug.
It is not recommended to use this drug in women in the first trimester of pregnancy.
In the second and third trimesters of pregnancy and during lactation, the drug can be used only if necessary.
Driving and operating machinery
Caution should be exercised, as in rare cases the ability to drive and operate machinery may be impaired.
The drug contains aspartame, benzoic acid, methyl parahydroxybenzoate, liquid maltitol, propylene glycol, ethanol, benzyl alcohol (components of caramel-orange flavor) and sodium
Aspartame
The drug contains 12.5 mg of aspartame in 5 ml of syrup. Aspartame is a source of phenylalanine. It can be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its abnormal excretion. See also "When not to use Supremin".
Benzoic acid
The drug contains 7.5 mg of benzoic acid in 5 ml of syrup.
Methyl parahydroxybenzoate
The drug may cause allergic reactions (possible late type reactions).
Liquid maltitol
If you have previously been diagnosed with intolerance to certain sugars, you should contact your doctor before taking the drug. The drug may have a slight laxative effect. Caloric value of 2.3 kcal/g of maltitol.
Propylene glycol
The drug contains 9.2 mg of propylene glycol per 5 ml of syrup.
Ethanol
This drug contains 6.2 mg of alcohol (ethanol) in 5 ml of syrup, which is equivalent to 0.16% v/v. The amount of alcohol in 5 ml of this drug is equivalent to less than 0.2 ml of beer or 0.06 ml of wine. The small amount of alcohol in this drug will not cause noticeable effects.
Benzyl alcohol
The drug contains 0.08 mg of benzyl alcohol per 5 ml of syrup.
Benzyl alcohol may cause allergic reactions.
Do not give to young children (under 3 years of age) for more than a week without the recommendation of a doctor or pharmacist.
Pregnant or breastfeeding women and patients with liver or kidney disease should consult a doctor before taking the drug, as large amounts of benzyl alcohol may accumulate in their bodies and cause adverse reactions (known as metabolic acidosis).
Sodium
The drug contains less than 1 mmol (23 mg) of sodium per 5 ml of syrup, that is, the drug is considered "sodium free."
Product identification
When not to use Supremin drug:
- if the patient is allergic to butamirate or any of the other ingredients of this drug (listed in section 6),
- in patients with phenylketonuria.
Warnings and precautions
Supremin drug is not indicated for use in patients with symptoms of severe respiratory inhibition. The drug should not be used for more than a few days.
Supremin and other drugs
There are no known interactions of the drug Supremin with other drugs.
Supremin with food and drink
The drug should be taken before meals.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, suspect that you may be pregnant or if you are planning to have a child, you should consult your doctor before taking this drug.
It is not recommended to use this drug in women in the first trimester of pregnancy.
In the second and third trimesters of pregnancy and during lactation, the drug can be used only if necessary.
Driving and operating machinery
Caution should be exercised, as in rare cases the ability to drive and operate machinery may be impaired.
The drug contains aspartame, benzoic acid, methyl parahydroxybenzoate, liquid maltitol, propylene glycol, ethanol, benzyl alcohol (components of caramel-orange flavor) and sodium
Aspartame
The drug contains 12.5 mg of aspartame in 5 ml of syrup. Aspartame is a source of phenylalanine. It can be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its abnormal excretion. See also "When not to use Supremin".
Benzoic acid
The drug contains 7.5 mg of benzoic acid in 5 ml of syrup.
Methyl parahydroxybenzoate
The drug may cause allergic reactions (possible late type reactions).
Liquid maltitol
If you have previously been diagnosed with intolerance to certain sugars, you should contact your doctor before taking the drug. The drug may have a slight laxative effect. Caloric value of 2.3 kcal/g of maltitol.
Propylene glycol
The drug contains 9.2 mg of propylene glycol per 5 ml of syrup.
Ethanol
This drug contains 6.2 mg of alcohol (ethanol) in 5 ml of syrup, which is equivalent to 0.16% v/v. The amount of alcohol in 5 ml of this drug is equivalent to less than 0.2 ml of beer or 0.06 ml of wine. The small amount of alcohol in this drug will not cause noticeable effects.
Benzyl alcohol
The drug contains 0.08 mg of benzyl alcohol per 5 ml of syrup.
Benzyl alcohol may cause allergic reactions.
Do not give to young children (under 3 years of age) for more than a week without the recommendation of a doctor or pharmacist.
Pregnant or breastfeeding women and patients with liver or kidney disease should consult a doctor before taking the drug, as large amounts of benzyl alcohol may accumulate in their bodies and cause adverse reactions (known as metabolic acidosis).
Sodium
The drug contains less than 1 mmol (23 mg) of sodium per 5 ml of syrup, that is, the drug is considered "sodium free."
SUPREMIN
4 mg/5 ml, syrup
Butamirati citras
4 mg/5 ml, syrup
Butamirati citras
Product Details
Reviews
No customer reviews for the moment.